ATS View
한국어

Ilyang Pharmaceutical KRX:007570KOSPI

일양약품 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h0
Articles, 7 days1
DART filings, 7 days0
Articles tracked45since Sep 11

In Q2 2026, Ilyang Pharmaceutical reported revenue of ₩65.1bn, up 3.9% year on year, and an operating loss of ₩6.8bn. Ilyang Pharmaceutical (일양약품) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Oct 21 with 3 articles.

Filing signals Swung to loss Screener

Ilyang Pharmaceutical quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩65.1bn+3.9%−₩6.8bn
margin −10.4%		−₩2.3bn
Q1 2026₩65.1bn+5.0%−₩7.4bn
margin −11.3%		₩17.0bn
Q4 2025 derived₩78.9bn+825.7%₩566m
margin 0.7%		−₩5.6bn
Q3 2025₩68.8bn-30.6%−₩158m
margin −0.2%		₩8.4bn
Q2 2025₩62.7bn+7.2%₩1.2bn
margin 1.9%		₩613m
Q1 2025₩62.0bn+5.5%₩3.4bn
margin 5.5%		₩3.8bn
Q4 2024 derived₩8.5bn+2284.0%−₩43m
margin −0.5%		₩2.2bn
Q3 2024₩99.1bn-1.5%₩5.5bn
margin 5.5%		₩3.8bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Ilyang Pharmaceutical top stories 2 weeks, by number of outlets

  1. 1
    일양약품, OTC '일양파모티딘정' 출시
    1 outlets · 1 articlesFirst report Oct 21 09:49 팜뉴스
  2. 2
    일양약품 ‘위제로 알파정’, 소화효소·제산제 담아 과식 뒤 속쓰림·더부룩함 겨냥
    1 outlets · 1 articlesFirst report Oct 21 11:20 코메디닷컴
  3. 3
    일양약품, 멀티비타민 '팝핑 프리미엄비타C' 출시
    1 outlets · 1 articlesFirst report Oct 21 10:27 핀포인트뉴스
  4. 4
    "오너家 절세 기회지만"…일양약품 주주는 '씁쓸'
    1 outlets · 1 articlesFirst report Oct 29 09:10 아시아타임즈

Latest Ilyang Pharmaceutical news Korean headlines